Insider · CIK 0001362490

Zankel Todd

Reports to the SEC for 2 companies · NOVATO, CA

sec.gov

Transactions

Companies

Filings

CIK

0001362490

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2012-09-25	HORIZON PHARMACEUTICAL LLCStock options (right to buy)A Award	Chief Scientific Officer	AAward	+35K sh	—	—	343,921
2012-09-04	HORIZON PHARMACEUTICAL LLCS Sale	Chief Scientific Officer	SSale	−842 sh	$5.00	−$4,210	651,866
2012-08-31	HORIZON PHARMACEUTICAL LLCStock options (right to buy)M Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	−3,642 sh	—	—	308,921
2012-08-31	HORIZON PHARMACEUTICAL LLCM Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	+3,642 sh	$2.83	+$10.3K	660,208
2012-08-31	HORIZON PHARMACEUTICAL LLCS Sale	Chief Scientific Officer	SSale	−3,642 sh	$5.00	−$18.2K	656,566
2012-08-31	HORIZON PHARMACEUTICAL LLCS Sale	Chief Scientific Officer	SSale	−3,858 sh	$5.00	−$19.3K	652,708
2012-08-30	HORIZON PHARMACEUTICAL LLCS Sale	Chief Scientific Officer	SSale	−2,648 sh	$5.00	−$13.2K	656,566
2012-08-29	HORIZON PHARMACEUTICAL LLCS Sale	Chief Scientific Officer	SSale	−10.1K sh	$5.01	−$50.8K	659,214
2012-08-27	HORIZON PHARMACEUTICAL LLCM Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	+287 sh	$2.02	+$579.74	669,637
2012-08-27	HORIZON PHARMACEUTICAL LLCStock options (right to buy)M Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	+287 sh	—	—	312,563
2012-08-27	HORIZON PHARMACEUTICAL LLCS Sale	Chief Scientific Officer	SSale	−287 sh	$5.00	−$1,435	669,350
2012-05-01	HORIZON PHARMACEUTICAL LLCStock options (right to buy)M Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	+3,643 sh	—	—	313,136
2012-05-01	HORIZON PHARMACEUTICAL LLCS Sale	Chief Scientific Officer	SSale	−17.5K sh	$5.84	−$102K	669,350
2012-05-01	HORIZON PHARMACEUTICAL LLCStock options (right to buy)M Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	+286 sh	—	—	312,850
2012-05-01	HORIZON PHARMACEUTICAL LLCM Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	+3,643 sh	$2.83	+$10.3K	690,477
2012-05-01	HORIZON PHARMACEUTICAL LLCM Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	+286 sh	$2.02	+$577.72	690,763
2012-05-01	HORIZON PHARMACEUTICAL LLCS Sale	Chief Scientific Officer	SSale	−3,929 sh	$5.82	−$22.9K	686,834
2012-02-09	HORIZON PHARMACEUTICAL LLCS Sale	Chief Scientific Officer	SSale	−200 sh	$7.80	−$1,561	691,436
2012-02-09	HORIZON PHARMACEUTICAL LLCS Sale	Chief Scientific Officer	SSale	−1,500 sh	$7.81	−$11.7K	689,936
2012-02-09	HORIZON PHARMACEUTICAL LLCS Sale	Chief Scientific Officer	SSale	−615 sh	$7.83	−$4,815.45	689,321
2012-02-09	HORIZON PHARMACEUTICAL LLCS Sale	Chief Scientific Officer	SSale	−2,100 sh	$7.83	−$16.5K	687,221
2012-02-09	HORIZON PHARMACEUTICAL LLCS Sale	Chief Scientific Officer	SSale	−100 sh	$7.84	−$784	687,121
2012-02-09	HORIZON PHARMACEUTICAL LLCS Sale	Chief Scientific Officer	SSale	−287 sh	$7.67	−$2,201.29	686,834
2012-02-09	HORIZON PHARMACEUTICAL LLCStock options (right to buy)M Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	+287 sh	—	—	316,779
2012-02-09	HORIZON PHARMACEUTICAL LLCStock options (right to buy)M Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	+3,643 sh	—	—	317,066
2012-02-09	HORIZON PHARMACEUTICAL LLCM Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	+3,643 sh	$2.83	+$10.3K	707,962
2012-02-09	HORIZON PHARMACEUTICAL LLCM Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	+287 sh	$2.02	+$579.74	708,249
2012-02-09	HORIZON PHARMACEUTICAL LLCS Sale	Chief Scientific Officer	SSale	−700 sh	$7.65	−$5,355	707,549
2012-02-09	HORIZON PHARMACEUTICAL LLCS Sale	Chief Scientific Officer	SSale	−1,500 sh	$7.66	−$11.5K	706,049
2012-02-09	HORIZON PHARMACEUTICAL LLCS Sale	Chief Scientific Officer	SSale	−1,443 sh	$7.67	−$11.1K	704,606
2012-02-09	HORIZON PHARMACEUTICAL LLCS Sale	Chief Scientific Officer	SSale	−1,470 sh	$7.67	−$11.3K	703,136
2012-02-09	HORIZON PHARMACEUTICAL LLCS Sale	Chief Scientific Officer	SSale	−600 sh	$7.68	−$4,608	702,536
2012-02-09	HORIZON PHARMACEUTICAL LLCS Sale	Chief Scientific Officer	SSale	−300 sh	$7.69	−$2,307	702,236
2012-02-09	HORIZON PHARMACEUTICAL LLCS Sale	Chief Scientific Officer	SSale	−300 sh	$7.70	−$2,308.5	701,936
2012-02-09	HORIZON PHARMACEUTICAL LLCS Sale	Chief Scientific Officer	SSale	−3,700 sh	$7.71	−$28.5K	698,236
2012-02-09	HORIZON PHARMACEUTICAL LLCS Sale	Chief Scientific Officer	SSale	−1,300 sh	$7.72	−$10K	696,936
2012-02-09	HORIZON PHARMACEUTICAL LLCS Sale	Chief Scientific Officer	SSale	−400 sh	$7.73	−$3,092	696,536
2012-02-09	HORIZON PHARMACEUTICAL LLCS Sale	Chief Scientific Officer	SSale	−700 sh	$7.74	−$5,418	695,836
2012-02-09	HORIZON PHARMACEUTICAL LLCS Sale	Chief Scientific Officer	SSale	−2,600 sh	$7.75	−$20.2K	693,236
2012-02-09	HORIZON PHARMACEUTICAL LLCS Sale	Chief Scientific Officer	SSale	−200 sh	$7.76	−$1,552	693,036
2012-02-09	HORIZON PHARMACEUTICAL LLCS Sale	Chief Scientific Officer	SSale	−1,400 sh	$7.80	−$10.9K	691,636
2011-09-22	HORIZON PHARMACEUTICAL LLCStock options (right to buy)A Award	Chief Scientific Officer	AAward	+87.3K sh	—	—	320,709
2011-09-22	HORIZON PHARMACEUTICAL LLCStock options (right to buy)A Award	Chief Scientific Officer	AAward	+29.1K sh	—	—	233,364
2011-09-22	HORIZON PHARMACEUTICAL LLCStock options (right to buy)A Award	Chief Scientific Officer	AAward	+87.3K sh	—	—	320,709
2011-09-22	HORIZON PHARMACEUTICAL LLCStock options (right to buy)A Award	Chief Scientific Officer	AAward	+29.1K sh	—	—	233,364
2011-07-26	HORIZON PHARMACEUTICAL LLCM Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	+4,950 sh	$2.02	+$9,999	704,319
2010-11-22	HORIZON PHARMACEUTICAL LLCStock options (right to buy)A Award	Chief Scientific Officer	AAward	+87.3K sh	—	—	165,526
2010-10-12	HORIZON PHARMACEUTICAL LLCStock Option (right to buy)A Award	Chief Scientific Officer	AAward	+43.7K sh	—	—	121,854
2010-03-09	HORIZON PHARMACEUTICAL LLCStock Option (right to buy)A Award	Chief Scientific Officer	AAward	+19.9K sh	—	—	78,181
2009-09-29	HORIZON PHARMACEUTICAL LLCCommon Stock Option (Right to Buy)A Award	Chief Scientific Officer	AAward	+58.3K sh	—	—	58,280

Recent filings

Accepted (ET)
Sep 284
Zankel Todd0001140361-12-041947
SEC(opens sec.gov)
Sep 54
Zankel Todd0001140361-12-039425
SEC(opens sec.gov)
Sep 44
Zankel Todd0001140361-12-039191
SEC(opens sec.gov)
Aug 314
Zankel Todd0001140361-12-039087
SEC(opens sec.gov)
Aug 294
Zankel Todd0001140361-12-038873
SEC(opens sec.gov)
May 24
Zankel Todd0001140361-12-022412
SEC(opens sec.gov)
Feb 104
Zankel Todd0001140361-12-007047
SEC(opens sec.gov)

Companies

Address

C/O RAPTOR PHARMACEUTICAL CORP. 9 COMMERCIAL BLVD., SUITE 200

NOVATO, CA, 94949